Erythrokeratodermia variabilis (EKV) is an autosomal dominant disease that causes skin lesions and thickening. In 2005, a novel mutation was identified in a small group of families with an atypical form of EKV. In addition to erythematous lesions and hyper-keratosis, affected individuals from these families have severe psychomotor retardation, peripheral neuropathy, sensorineural hearing loss and severe diarrhea. In a new study, a team of Canadian researchers report that the atypical form of EKV caused by this mutation is in fact a novel neurocu-taneous syndrome, which they have named MEDNIK (mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis and keratodermia). The mutation found in MEDNIK patients creates a premature stop codon in the AP1S1 gene, which encodes a subunit of an adaptor protein complex involved in protein trafficking within cells. The researchers show that knocking down Ap1s1 expression in zebrafish resulted in a phenotype reminiscent of the human syndromes, featuring aberrant skin formation and severe motor deficits owing to impaired neurodevelopment. Furthermore, injection of wild-type human AP1S1 mRNA rescued this phenotype, but injection of AP1S1 mRNA containing the MEDNICK mutation did not. These results confirm the role of this adapter protein subunit in the pathology of this newly reported disease.
Development: zebrafish used in identifying a novel neurocutaneous syndrome Open Access
Development: zebrafish used in identifying a novel neurocutaneous syndrome. Dis Model Mech 7 January 2009; 2 (1-2): 2. doi:
Download citation file:
Advertisement
Cited by
Call for papers – In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery

We invite you to submit your latest research to our upcoming special issue: In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery, coordinated by DMM Editor Vivian Li (The Francis Crick Institute, London, UK), alongside Guest Editors Austin Smith (University of Exeter, UK) and Joseph Wu (Stanford University School of Medicine, USA).The deadline for submitting articles is 6 October 2025.
The Company of Biologists Workshops

For the last 15 years, our publisher, The Company of Biologists, has provided an apt environment to inspire biology and support biologists through our Workshops series. Read about the evolution of the Workshop series and revisit JEB's experience with hosting the first Global South Workshop.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
Propose a new Workshop for 2027

We are currently seeking proposals for Workshops to be held in 2027. As one of the scientific organisers of a The Company of Biologists Workshop, your involvement will be focused on interdisciplinary, cutting-edge science and promoting new partnerships and collaborations. We focus on the logistics. Are you thinking about proposing a topic for one of our Workshops? Apply by Friday 30 May 2025.
Other journals from
The Company of Biologists